Loading...
Loading...
By Jorge Ramos Zwanziger - Mon, 06/28/2021 - 18:31
Researchers highlight that a delayed second dose of the AstraZeneca vaccine enhances immune response, which could be beneficial for Mexico.
Featured content
Thu, 04/11/2024 - 15:25
Current regulation in Mexico hinders the full development of healthcare markets, including cannabis and AI, says BPF’s Jaime Castro.
https://mexicobusiness.news/tag/oxford-university
More Health
By Miriam Bello - Thu, 01/07/2021 - 13:33
COVID-19 vaccine developments keep bringing positive news. Moderna might be the next in line for emergency approval.
By Miriam Bello - Thu, 09/24/2020 - 16:33
As COVID-19 vaccine developments move forward, so does Mexico on finding access to such cure.
By Miriam Bello - Thu, 09/17/2020 - 16:45
On Independence Day, Mexico put the medical staff at the center of the celebrations.
By Miriam Bello - Thu, 09/10/2020 - 14:20
Vaccines, management and budgets deliver mixed news this week. Don’t miss the most important news of the industry!
By Miriam Bello - Wed, 09/09/2020 - 16:57
AstraZeneca and Oxford University trials on the development of the COVID-19 vaccine had to be stopped due to a possible adverse reaction.
By Miriam Bello - Thu, 07/30/2020 - 12:56
Despite the public and private sectors declaring their will to cooperate, being on the same page is key to begin action.
By Miriam Bello - Mon, 07/20/2020 - 13:08
Scientific research advances at a good pace. Here are the most advanced treatments for the COVID-19 virus.
By Miriam Bello - Thu, 06/04/2020 - 10:00
Mexico began “new normal” activities this week. What do figures say about this risky return?
By Miriam Bello - Thu, 04/30/2020 - 16:30
Trials with Remdesivir lead to optimism in finding a treatment against COVID-19
